7-16532519-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001195280.2(LRRC72):āc.115T>Cā(p.Cys39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000284 in 1,550,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001195280.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC72 | NM_001195280.2 | c.115T>C | p.Cys39Arg | missense_variant | 2/9 | ENST00000401542.3 | NP_001182209.1 | |
LRRC72 | XM_011515057.2 | c.115T>C | p.Cys39Arg | missense_variant | 2/10 | XP_011513359.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC72 | ENST00000401542.3 | c.115T>C | p.Cys39Arg | missense_variant | 2/9 | 5 | NM_001195280.2 | ENSP00000384971.2 | ||
LRRC72 | ENST00000382124.7 | n.115T>C | non_coding_transcript_exon_variant | 2/4 | 3 | ENSP00000371558.3 | ||||
LRRC72 | ENST00000482711.1 | n.178T>C | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000333 AC: 5AN: 150136Hom.: 0 AF XY: 0.0000124 AC XY: 1AN XY: 80606
GnomAD4 exome AF: 0.0000143 AC: 20AN: 1397824Hom.: 0 Cov.: 30 AF XY: 0.00000870 AC XY: 6AN XY: 689458
GnomAD4 genome AF: 0.000158 AC: 24AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74378
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at